Youn Jae Lee

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Michael Manns, S. Pol, Ira M. Jacobson et al. · The Lancet · 2014 · 343 citations

Multicohort Study, Hepatitis C, Viral Hepatitis +9

Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial

Joong‐Won Park, Yoon Jun Kim, Do Young Kim et al. · Journal of Hepatology · 2018 · 194 citations · Full text

Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Masatoshi Kudo, Ann‐Lii Cheng, Joong‐Won Park et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 189 citations

Hepatology, Medicine, Transcatheter Arterial Chemoembolisation +9

The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers

Won Hee Jang, Young‐Il Yang, Sung Su Yea et al. · Cancer Letters · 2001 · 165 citations

Tumor Biology, Cancer Risk, Medicine +7

A nationwide seroepidemiology of hepatitis C virus infection in South Korea

Do Young Kim, In Hee Kim, Sook‐Hyang Jeong et al. · Liver International · 2013 · 87 citations · Full text